These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32359644)

  • 41. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.
    Sheikh MS; Shao ZM; Li XS; Dawson M; Jetten AM; Wu S; Conley BA; Garcia M; Rochefort H; Fontana JA
    J Biol Chem; 1994 Aug; 269(34):21440-7. PubMed ID: 8063776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping.
    Keidel S; LeMotte P; Apfel C
    Mol Cell Biol; 1994 Jan; 14(1):287-98. PubMed ID: 8264595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors.
    Heery DM; Zacharewski T; Pierrat B; Gronemeyer H; Chambon P; Losson R
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4281-5. PubMed ID: 8387213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation.
    Botling J; Castro DS; Oberg F; Nilsson K; Perlmann T
    J Biol Chem; 1997 Apr; 272(14):9443-9. PubMed ID: 9083083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
    Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
    Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter.
    Nagy L; Saydak M; Shipley N; Lu S; Basilion JP; Yan ZH; Syka P; Chandraratna RA; Stein JP; Heyman RA; Davies PJ
    J Biol Chem; 1996 Feb; 271(8):4355-65. PubMed ID: 8626785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.
    Angulo A; Suto C; Heyman RA; Ghazal P
    Mol Endocrinol; 1996 Jul; 10(7):781-93. PubMed ID: 8813719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors.
    Yang Y; Minucci S; Ozato K; Heyman RA; Ashwell JD
    J Biol Chem; 1995 Aug; 270(31):18672-7. PubMed ID: 7629199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
    Jiménez-Lara AM; Aranda A
    Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells.
    Gillespie RF; Gudas LJ
    J Mol Biol; 2007 Sep; 372(2):298-316. PubMed ID: 17663992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic retinoids dissociate coactivator binding from corepressor release.
    Zechel C
    J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors.
    Takeshita A; Watanabe A; Takada Y; Hanazawa S
    J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.
    Jansen JH; Mahfoudi A; Rambaud S; Lavau C; Wahli W; Dejean A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7401-5. PubMed ID: 7638205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of nuclear retinoic acid receptor and retinoid X receptor mRNA in the cornea and conjunctiva.
    Bossenbroek NM; Sulahian TH; Ubels JL
    Curr Eye Res; 1998 May; 17(5):462-9. PubMed ID: 9617539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling.
    Bajpe PK; Heynen GJ; Mittempergher L; Grernrum W; de Rink IA; Nijkamp W; Beijersbergen RL; Bernards R; Huang S
    Mol Cell Biol; 2013 Aug; 33(16):3343-53. PubMed ID: 23775127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Didehydroretinoic acid: retinoid receptor-mediated transcriptional activation and binding properties.
    Sani BP; Venepally PR; Levin AA
    Biochem Pharmacol; 1997 Apr; 53(7):1049-53. PubMed ID: 9174119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.